BY Advocate.com Editors
August 30 2002 12:00 AM ET
Cancer drug shows promise in treating K.S.
Phase II human trials of Bristol-Myers Squibb's anticancer drug paclitaxel--already approved to treat some cases of breast, ovarian, and lung cancers under the brand name Taxol--have shown that the drug is effective in treating advanced AIDS-related Kaposi's sarcoma, AIDS Policy & Law reports. The medication appears most useful in treating K.S. in patients who have failed other chemotherapy agents. The drug was evaluated in 107 male patients with advanced K.S. who had failed at least one previous regimen of systemic chemotherapy. More than half of the patients experienced a complete or partial response to the drug. Additional data from the clinical trial is expected to be released later this year. Phase III trials are planned.
Sign Up For Email Updates
- Commentary Can Marc Carson's Murder Have as Much Impact as Matthew Shepard's? 2 hours 47 min ago
- Music The Comeback: ABBA's Agnetha Fältskog 8:49 AM
- Travel 10 of Europe's Gayest Beaches 7:33 AM
- Current Issue The South's Longer Wait for Equality 4:00 AM
- Current Issue Editor's Letter: Why One Couple's Story Should Worry You 4:00 AM
- Current Issue The Small Southwestern Town That Went Rogue 4:00 AM
- Arts & Entertainment Week in Beef: Ben Cohen, Frank Ocean, Hugh Jackman, and More Shirtless Celebs May 19 2013 6:02 PM